Expert Review Of Clinical Immunology

Expert Review of Clinical Immunology (ISSN 1744-666X) provides expert analysis and commentary regarding the performance of new therapeutic and diagnostic modalities in clinical immunology. Members of the International Editorial Advisory Panel of Expert Review of Clinical Immunology are the forefront of their area of expertise. This panel works with our dedicated editorial team to identify the most important and topical review themes and the corresponding expert(s) most appropriate to provide commentary and analysis. All articles are subject to rigorous peer-review, and the finished reviews provide an essential contribution to decision-making in clinical immunology.

Articles focus on the following key areas:

• Therapeutic overviews of specific immunologic disorders highlighting optimal therapy and prospects for new medicines

• Performance and benefits of newly approved therapeutic agents

• New diagnostic approaches

• Screening and patient stratification

• Pharmacoeconomic studies

• New therapeutic indications for existing therapies

• Adverse effects, occurrence and reduction

• Prospects for medicines in late-stage trials approaching regulatory approval

• Novel treatment strategies

• Epidemiological studies

• Commentary and comparison of treatment guidelines

Topics include infection and immunity, inflammation, host defense mechanisms, congenital and acquired immunodeficiencies, anaphylaxis and allergy, systemic immune diseases, organ-specific inflammatory diseases, transplantation immunology, endocrinology and diabetes, cancer immunology, neuroimmunology and hematological diseases.

《临床免疫学专家评论》（ISSN 1744-666X）提供有关临床免疫学中新治疗和诊断方式表现的专家分析和评论。《临床免疫学专家评论》国际编辑顾问小组的成员是各自专业领域的领军人物。该小组与我们专门的编辑团队合作，确定最重要的热门评论主题以及最适合提供评论和分析的相应专家。所有文章均经过严格的同行评审，完成的评审结果将为临床免疫学决策提供重要贡献。

文章重点关注以下关键领域：

• 特定免疫疾病的治疗概述，重点介绍最佳治疗方法和新药前景

• 新批准治疗药物的性能和益处

• 新的诊断方法

• 筛查和患者分层

• 药物经济学研究

• 现有疗法的新治疗指征

• 不良反应、发生和减少

• 即将获得监管部门批准的处于后期试验阶段的药物前景

• 新的治疗策略

• 流行病学研究

• 治疗指南的评论和比较

主题包括感染和免疫、炎症、宿主防御机制、先天性和获得性免疫缺陷、过敏反应和变态反应、全身免疫疾病、器官特异性炎症疾病、移植免疫学、内分泌学和糖尿病、癌症免疫学、神经免疫学和血液学疾病。

该刊已被国际权威数据库SCIE收录，该刊致力于发表经过严格同行评审的高质量原创文章，反映IMMUNOLOGY领域的新进展、新技术、新成果，促进该领域科研交流和科研成果转化。该刊2023年影响因子为3.9，平均审稿速度为 较慢,6-12周 ，近四年来没有被列入预警名单。如果您需要投稿发表服务及指导，可以联系我们的客服老师，我们专业专注服务期刊投稿协助10年，为您提供期刊投稿个性化定制服务，并且我们确保严格保密您的个人信息及稿件内容。